Key facts
- Materna Medical’s last known valuation is $110.0M (Jun 2025).
- It has raised $57.7M across 5 recorded rounds; the latest was Early Stage VC ($10.8M) in May 2024.
- Notable investors include Gaingels, Springboard Enterprises, Mayfield Fund, Band of Angels, Wealthing VC Club — 31 tracked in total.
- Materna Medical has filed 7 Form Ds with the SEC since 2010, most recently Jun 2025 ($10.8M sold to 36 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 31 names
- ·Watchlist + deal alerts for Materna Medical
Funding rounds
5 roundsAbout Materna Medical
Developer of a medical device designed to empower women to protect and restore their pelvic health. The company's devices permit mothers to maximize control over natural labor and delivery to prevent common complications, stress, and muscle injuries, enabling users to take control of their intimate pelvic health and their postpartum phase.
- Industry
- Therapeutic Devices
- Sector
- Healthcare
- HQ
- Mountain View, CA, United States
- Founded
- 2010
- Employees
- 45
- Website
- maternamedical.com/
- Ownership
- Privately Held (backing)
Materna Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Materna Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Materna Medical in its N-PORT filings yet. We sweep new filings monthly.